ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Construction and experimental validation of a B cell senescence-related gene signature to evaluate prognosis and immunotherapeutic sensitivity in bladder cancer

Zhou, Ranran; Zhou, Jiawei; Muhuitijiang, Bahaerguli; Tan, Wanlong*南方医科大学; 1
FUNCTIONAL & INTEGRATIVE GENOMICS2023-3DOI: 10.1007/s10142-022-00936-7
2被引4阅读
引用收藏
分享

摘要

Senescent B cells exhibit reduced antibody production and enhanced proinflammatory cytokine and chemokine secretion, exerting non-negligible functions in antitumor immunity. This study aims to clarify the prognosis value of B cell senescence-related genes in bladder cancer (BLCA). Twelve B cell senescence-related genes were identified based on previous studies and the single-cell RNA sequencing of a BLCA sample from Gene Expression Omnibus (GEO). The Cancer Genome Atlas BLCA cohort was used as the training dataset. Three cohorts from GEO, 35 clinical samples from the local hospital, and in vitro cell experiments were used for validation. The unsupervised clustering based on the 12 genes was associated with the prognosis and the tumor immunity. Through least absolute shrinkage and selection operator regression and random forest algorithm, G protein subunit gamma 11 (GNG11) and inhibitor of DNA binding 1 (ID1) of the 12 genes were determined as significant prognosis predictors and then included in the multivariate Cox regression model. The model was a reliable and robust prognosis biomarker across multiple large-scale cohorts (pooled HR = 1.76, 95% CI = 1.41-2.20). The tight association between the model and BLCA malignant degree was demonstrated in the local cohort (P < 0.01). The model could also predict the immunotherapeutic sensitivity, which was confirmed by the tumor immune dysfunction and exclusion algorithm (P < 0.0001) and IMvigor210 cohort (P < 0.0001). At last, in vitro cell experiments in IM-9 and GM12878 B cells indicated that GNG11 and ID1 were involved in the cellular aging process. Collectively, a B cell senescence-related gene signature was constructed to evaluate the prognosis and immunotherapeutic response in BLCA, providing novel insights into the biological mechanisms.

学科与关键词

关键词
Bladder cancerTumor immunityB cellSenescenceImmunotherapy
相关
加载中…
  • Construction and experimental validation of a B cell-related gene signature to predict the prognosis and immunotherapeutic sensitivity in bladder cancer
    Zhou, Ranran; Zhou, Jiawei; Muhuitijiang, Bahaerguli; Zeng, Xiangbo; Tan, Wanlong*Aging-US, 2023, 15(12): 5355-5380.
  • An Immunosenescence-Related Gene Signature to Evaluate the Prognosis, Immunotherapeutic Response, and Cisplatin Sensitivity of Bladder Cancer
    Zhou, Ranran; Liang, Jingjing; Tian, Hu; Chen, Qi; Yang, Cheng; Liu, Cundong*DISEASE MARKERS, 2022, 2022: 2143892.被引 2
  • Construction and experimental validation of a macrophage cell senescence-related gene signature to evaluate the prognosis, immunotherapeutic sensitivity, and chemotherapy response in bladder cancer
    Jiang, Qijun; Zhou, Junhao; Chen, Qi; Huang, Yuliang; Yang, Cheng; Liu, Cundong*FUNCTIONAL & INTEGRATIVE GENOMICS, 2023, 23(3): 228.
查看全部 →

发表信息

论文状态
公开发表
期刊
FUNCTIONAL & INTEGRATIVE GENOMICS
发表日期
2023-03
卷期
第 23 卷, 第 1 期
页码
3
DOI
10.1007/s10142-022-00936-7
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China; [82073162]

作者

  • Z

    Zhou, Ranran (第一作者)

    southern med univ · 1

  • Z

    Zhou, Jiawei

    southern med univ · 1

查看全部 4 位作者收起作者
  • M

    Muhuitijiang, Bahaerguli

    southern med univ · 1

  • T

    Tan, Wanlong (通讯)

    southern med univ · 1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417